Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Samuel M Meier-Menches

Showing results (1-10 of 55) with videos related to

Pageof 6
Sort By:
Bioconjugate Chemistry|April 4, 2020
Design Strategies and Medicinal Applications of Metal-Peptidic BioconjugatesSamuel M Meier-Menches, Angela Casini
Chembiochem : a European Journal of Chemical Biology|June 22, 2023
Exploring the Potential of Metal-Based Candidate Drugs as Modulators of the CytoskeletonYasmin Borutzki, Lukas Skos, Christopher Gerner, et al.
Current Opinion in Chemical Biology|January 4, 2023
Methods to identify protein targets of metal-based drugsLukas Skos, Yasmin Borutzki, Christopher Gerner, et al.
Chemical Communications (Cambridge, England)|June 28, 2017
On the binding modes of metal NHC complexes with DNA secondary structures: implications for therapy and imagingÖzden Karaca, Samuel M Meier-Menches, Angela Casini, et al.
Metallomics : Integrated Biometal Science|May 17, 2018
Aquaporins in cancer development: opportunities for bioinorganic chemistry to contribute novel chemical probes and therapeutic agentsBrech Aikman, Andreia de Almeida, Samuel M Meier-Menches, et al.
Journal of Inorganic Biochemistry|July 26, 2017
Characterizing activation mechanisms and binding preferences of ruthenium metallo-prodrugs by a competitive binding assayChristian Artner, Hannah U Holtkamp, Christian G Hartinger, et al.
Chemical Society Reviews|November 25, 2017
Structure-activity relationships for ruthenium and osmium anticancer agents - towards clinical developmentSamuel M Meier-Menches, Christopher Gerner, Walter Berger, et al.
Chemical Communications (Cambridge, England)|January 3, 2018
Selective targeting of PARP-1 zinc finger recognition domains with Au(iii) organometallicsMargot N Wenzel, Samuel M Meier-Menches, Thomas L Williams, et al.
Metallomics : Integrated Biometal Science|August 15, 2018
Time-dependent shotgun proteomics revealed distinct effects of an organoruthenium prodrug and its activation product on colon carcinoma cellsSamuel M Meier-Menches, Katja Zappe, Andrea Bileck, et al.
The EPMA Journal|June 30, 2021
Metabo-tip: a metabolomics platform for lifestyle monitoring supporting the development of novel strategies in predictive, preventive and personalised medicineJulia Brunmair, Andrea Bileck, Thomas Stimpfl, et al.
Pageof 6

Showing results (1-10 of 55) with videos related to

Sort By:
Pageof 6
Bioconjugate Chemistry|April 4, 2020
Design Strategies and Medicinal Applications of Metal-Peptidic BioconjugatesSamuel M Meier-Menches, Angela Casini
Chembiochem : a European Journal of Chemical Biology|June 22, 2023
Exploring the Potential of Metal-Based Candidate Drugs as Modulators of the CytoskeletonYasmin Borutzki, Lukas Skos, Christopher Gerner, et al.
Current Opinion in Chemical Biology|January 4, 2023
Methods to identify protein targets of metal-based drugsLukas Skos, Yasmin Borutzki, Christopher Gerner, et al.
Chemical Communications (Cambridge, England)|June 28, 2017
On the binding modes of metal NHC complexes with DNA secondary structures: implications for therapy and imagingÖzden Karaca, Samuel M Meier-Menches, Angela Casini, et al.
Metallomics : Integrated Biometal Science|May 17, 2018
Aquaporins in cancer development: opportunities for bioinorganic chemistry to contribute novel chemical probes and therapeutic agentsBrech Aikman, Andreia de Almeida, Samuel M Meier-Menches, et al.
Journal of Inorganic Biochemistry|July 26, 2017
Characterizing activation mechanisms and binding preferences of ruthenium metallo-prodrugs by a competitive binding assayChristian Artner, Hannah U Holtkamp, Christian G Hartinger, et al.
Chemical Society Reviews|November 25, 2017
Structure-activity relationships for ruthenium and osmium anticancer agents - towards clinical developmentSamuel M Meier-Menches, Christopher Gerner, Walter Berger, et al.
Chemical Communications (Cambridge, England)|January 3, 2018
Selective targeting of PARP-1 zinc finger recognition domains with Au(iii) organometallicsMargot N Wenzel, Samuel M Meier-Menches, Thomas L Williams, et al.
Metallomics : Integrated Biometal Science|August 15, 2018
Time-dependent shotgun proteomics revealed distinct effects of an organoruthenium prodrug and its activation product on colon carcinoma cellsSamuel M Meier-Menches, Katja Zappe, Andrea Bileck, et al.
The EPMA Journal|June 30, 2021
Metabo-tip: a metabolomics platform for lifestyle monitoring supporting the development of novel strategies in predictive, preventive and personalised medicineJulia Brunmair, Andrea Bileck, Thomas Stimpfl, et al.
Pageof 6